Janus Henderson Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,539
| Closed | -$417K | – | 2602 |
|
|
2024
Q1 | $417K | Buy |
26,539
+2
| +0% | +$31 | ﹤0.01% | 2091 |
|
|
2023
Q4 | $428K | Sell |
26,537
-90
| -0.3% | -$1.45K | ﹤0.01% | 2066 |
|
|
2023
Q3 | $338K | Buy |
26,627
+21
| +0.1% | +$267 | ﹤0.01% | 2136 |
|
|
2023
Q2 | $374K | Buy |
26,606
+15,102
| +131% | +$213K | ﹤0.01% | 2134 |
|
|
2023
Q1 | $178K | Buy |
+11,504
| New | +$178K | ﹤0.01% | 2521 |
|
|
2021
Q4 | – | Sell |
-407,237
| Closed | -$13.8M | – | 2600 |
|
|
2021
Q3 | $13.8M | Buy |
407,237
+109
| +0% | +$3.7K | 0.01% | 859 |
|
|
2021
Q2 | $14.9M | Sell |
407,128
-18,949
| -4% | -$694K | 0.01% | 857 |
|
|
2021
Q1 | $19.1M | Buy |
426,077
+91,239
| +27% | +$4.09M | 0.01% | 773 |
|
|
2020
Q4 | $19.1M | Sell |
334,838
-468
| -0.1% | -$26.7K | 0.01% | 758 |
|
|
2020
Q3 | $17.2M | Buy |
335,306
+304
| +0.1% | +$15.6K | 0.01% | 740 |
|
|
2020
Q2 | $20M | Sell |
335,002
-1,334
| -0.4% | -$79.7K | 0.01% | 696 |
|
|
2020
Q1 | $13.8M | Sell |
336,336
-461,888
| -58% | -$19M | 0.01% | 759 |
|
|
2019
Q4 | $49.7M | Sell |
798,224
-97,057
| -11% | -$6.04M | 0.03% | 595 |
|
|
2019
Q3 | $30.4M | Buy |
895,281
+219,574
| +32% | +$7.45M | 0.02% | 726 |
|
|
2019
Q2 | $15.2M | Buy |
675,707
+14,028
| +2% | +$316K | 0.01% | 854 |
|
|
2019
Q1 | $15.4M | Sell |
661,679
-40,817
| -6% | -$947K | 0.01% | 829 |
|
|
2018
Q4 | $14.7M | Buy |
702,496
+22,998
| +3% | +$483K | 0.01% | 827 |
|
|
2018
Q3 | $26.3M | Buy |
679,498
+120,683
| +22% | +$4.67M | 0.01% | 751 |
|
|
2018
Q2 | $22M | Buy |
+558,815
| New | +$22M | 0.01% | 778 |
|